Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Long-Term Investments (2019 - 2025)

Phibro Animal Health has reported Long-Term Investments over the past 7 years, most recently at $367000.0 for Q4 2025.

  • Quarterly results put Long-Term Investments at $367000.0 for Q4 2025, down 93.31% from a year ago — trailing twelve months through Dec 2025 was $367000.0 (down 93.31% YoY), and the annual figure for FY2025 was $89000.0, down 98.28%.
  • Long-Term Investments for Q4 2025 was $367000.0 at Phibro Animal Health, up from $42000.0 in the prior quarter.
  • Over the last five years, Long-Term Investments for PAHC hit a ceiling of $13.4 million in Q4 2022 and a floor of $42000.0 in Q3 2025.
  • Median Long-Term Investments over the past 5 years was $5.0 million (2021), compared with a mean of $5.5 million.
  • Biggest five-year swings in Long-Term Investments: soared 381.31% in 2022 and later tumbled 99.34% in 2025.
  • Phibro Animal Health's Long-Term Investments stood at $4.7 million in 2021, then skyrocketed by 183.38% to $13.4 million in 2022, then tumbled by 67.22% to $4.4 million in 2023, then rose by 25.24% to $5.5 million in 2024, then plummeted by 93.31% to $367000.0 in 2025.
  • The last three reported values for Long-Term Investments were $367000.0 (Q4 2025), $42000.0 (Q3 2025), and $89000.0 (Q2 2025) per Business Quant data.